U.S. Banks Stock News

If you are wondering whether RingCentral's current share price still reflects its true value, you are not alone, especially after years of sharp swings in sentiment. The stock closed at US$25.90, with returns of a 10.2% decline over the past week, 12.7% decline over the past month, and 6.1% decline year to date, adding to a 24.0% decline over 1 year and 31.0% decline over 3 years, while the 5 year return sits at a much larger 92.8% decline. These moves have come alongside ongoing investor...

Quite a few Enterprise Financial Services Corp ( NASDAQ:EFSC ) insiders sold their shares over the past year, which may...

PACS Group stock snapshot after recent performance moves PACS Group (PACS) has drawn fresh attention after a mixed recent performance, with a 1% gain in the latest session alongside a 9% decline over the past week and a month of modest softness. Over the past 3 months, the stock shows a very large total return, while the 1 year total return sits around 156%. Year to date, shares reflect a 9% decline, highlighting meaningful volatility for investors to weigh. See our latest analysis for PACS...

The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...

Tango Therapeutics (TNGX) is in focus after founding CEO and President Dr. Barbara Weber retired, with board member Dr. Malte Peters stepping in as President and CEO, while she transitions to Executive Chair. See our latest analysis for Tango Therapeutics. The leadership change follows a period of strong price momentum, with Tango Therapeutics posting a 45.13% 1‑month share price return and a 66.14% 3‑month share price return, while its 1‑year total shareholder return is just over 3x. If this...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Investors may be wondering if Reynolds Consumer Products, at around US$24.28 a share, still offers solid value or if most of the opportunity is already reflected in the price. Over the short term, the stock has been fairly steady, with a 0.2% decline over 7 days, a 3.1% gain over 30 days, and a 5.3% return year to date. The 1 year return sits at an 8.7% decline, and the 3 and 5 year returns are 8.2% and 8.9% declines respectively. Recent attention on household and consumer staples companies...

Murphy Oil (NYSE:MUR) reported that its Civette-1X exploration well offshore Côte d'Ivoire encountered non-commercial hydrocarbons. The result, in Block CI-502, was announced as an early-stage outcome that will inform the company's international exploration efforts. Murphy Oil plans to focus next on the nearby Caracal and Bubale prospects in the same offshore area. Murphy Oil, an independent exploration and production company, is using this early result from Civette-1X as a data point for...

ServisFirst Bancshares (SFBS) capped FY 2025 with fourth quarter revenue of US$154.3 million and EPS of US$1.58, as trailing twelve month figures reached US$527.1 million in revenue and EPS of US$5.06. Over the past year, revenue has moved from US$458.7 million on a trailing basis to US$527.1 million, while EPS over the same period shifted from US$4.17 to US$5.06, providing additional context for how you might think about the bank’s earnings power. With a trailing net profit margin of 52.5%...

Charles Schwab FY 2025 Earnings Snapshot Charles Schwab (SCHW) closed FY 2025 with fourth quarter revenue of US$6.3 billion and basic EPS of US$1.34, alongside net income excluding extra items of US$2.4 billion, putting a solid set of headline numbers in front of investors. The company has seen quarterly revenue move from US$5.3 billion and EPS of US$0.94 in Q4 2024 to US$6.3 billion and EPS of US$1.34 in Q4 2025, alongside trailing twelve month EPS of US$4.67 and revenue of US$24.0 billion...

United Airlines FY 2025 Earnings Snapshot United Airlines Holdings (UAL) has wrapped up FY 2025 with Q4 revenue of US$15.4b and basic EPS of US$3.19, supported by net income of US$1,044m. Over recent quarters, the company has seen revenue move from US$14.7b in Q4 2024 to US$15.2b in Q3 2025 and US$15.4b in Q4 2025. Basic EPS over the same Q4 periods shifted from US$2.94 to US$3.19, setting up a results season where investors can weigh steady top line and earnings against how efficiently those...

In mid-January 2026, Sensata Technologies announced the launch of its STEV high-voltage contactor series, a scalable, customizable solution designed to improve safety, efficiency and integration across battery electric and plug-in hybrid vehicle platforms from passenger cars to heavy-duty trucks. A distinctive aspect of the STEV lineup is its combination of bidirectional current capability, hermetic ceramic sealing and global in-region manufacturing, positioning Sensata as a key enabler of...

Teledyne Technologies (TDY) has wrapped up FY 2025 with fourth quarter revenue of US$1.6b and basic EPS of US$5.60, alongside trailing twelve month revenue of US$6.1b and EPS of US$18.88 that frame the latest print in a broader earnings run. Over the past six quarters in the data, quarterly revenue has ranged from US$1.44b to US$1.61b, while basic EPS has moved between US$4.03 and US$5.61, giving investors a clear view of how the top and bottom lines have tracked together through recent...

If you are wondering whether Universal Technical Institute's share price still offers value after recent moves, it helps to step back and look at what the current market price might be implying. The stock last closed at US$28.15, with returns of 5.9% over the past week, 5.0% over the last month, 13.3% year to date, 6.1% over 1 year, and very large gains over 3 and 5 years. Recent attention on Universal Technical Institute has focused on its role in career and technical education, as...

Riverwater Partners recently highlighted IRADIMED CORPORATION as the top contributor to its Micro Opportunities Strategy in 2025, following record Q3 2025 revenue of US$21.2 million and FDA approval of the company’s MRI-compatible 3870 IV infusion pump in July 2025. Beyond the financial headlines, IRADIMED’s combination of accelerating revenue, new FDA-cleared technology and a special dividend, alongside insider share sales and a “Moderate Buy” analyst consensus, paints a complex picture of...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

AbCellera Biologics (ABCL) has begun dosing patients in the Phase 2 portion of its Phase 1/2 trial for ABCL635, a potential first in class non hormonal treatment for menopausal vasomotor symptoms. See our latest analysis for AbCellera Biologics. The ABCL635 Phase 2 start comes as AbCellera’s 30 day share price return of 15.05% and year to date share price return of 24.78% contrast with a 3 year total shareholder return of 58.89% decline, suggesting sentiment has improved recently after a...

If you are wondering whether Newmark Group's share price still offers value after a long run on the market, this article breaks down what the current valuation implies for you as a shareholder or potential investor. Newmark Group's stock last closed at US$17.75, with returns of 5.7% over 7 days, 1.5% over 30 days, 4.6% year to date, 30.1% over 1 year and 113.0% over 3 years. These figures raise fair questions about how much of the story is already reflected in the price. Recent coverage has...

National Bank Financial recently upgraded RB Global (NYSE:RBA), highlighting market share gains and contract wins in Australia and the UK. The firm pointed to new agreements with Suncorp and Direct Line as key drivers of RB Global's expanding presence in vehicle and asset remarketing. The upgrade focuses on the company's growing international footprint and its potential to win additional business in core markets. RB Global runs auctions and related services that help businesses sell heavy...

Commerce Bancshares (NasdaqGS:CBSH) has closed its acquisition of FineMark National Bank & Trust. The deal expands Commerce's wealth management and private banking reach into Florida, Arizona, and South Carolina. FineMark will operate as a division within Commerce Bank while maintaining existing client relationships. For investors, this move adds more scale and breadth to Commerce Bancshares' long standing banking and wealth management franchise. Wealth management and private banking have...

Event context and recent stock performance Amicus Therapeutics (FOLD) has caught investor attention after a sharp share price move in the past 3 months, with the stock returning about 69% over that period. See our latest analysis for Amicus Therapeutics. That sharp 68.82% 90 day share price return sits alongside a 50.42% 1 year total shareholder return, while the 5 year total shareholder return of a 24.39% decline shows longer term holders have had a tougher journey, which suggests that...

Latest FY 2025 Earnings Snapshot Interactive Brokers Group (IBKR) closed out FY 2025 with Q4 total revenue of US$1.7b and basic EPS of US$0.64, alongside net income of US$284m, setting a clear reference point for the year just finished. The company has seen quarterly revenue move from US$1.4b in Q1 2025 to US$1.7b in Q4 2025, while basic EPS has ranged from US$0.49 in Q1 to US$0.64 in Q4, providing a clear view of how the top and bottom line have tracked through the year as you weigh the...

If you are wondering whether Ormat Technologies at around US$122 is priced attractively or asking too much, you are not alone. The stock shows returns of 1.9% over 7 days, 8.8% over 30 days, 7.3% year to date, 90.4% over 1 year, 35.1% over 3 years and 10.4% over 5 years. This naturally raises questions about how this performance lines up with the current share price. Recent news coverage has focused on Ormat Technologies as a US listed utilities business with exposure to renewable energy...

Solstice Advanced Materials, Inc. ( NASDAQ:SOLS ) shares have continued their recent momentum with a 27% gain in the...